-
Dr Sanil RegeJanuary 21, 2023
Time to read: 8 minutes
Varenicline (CHANTIX /CHAMPIX) is a nicotinic acetylcholine receptor (nAChR) partial agonist indicated as a smoking cessation drug. ...
READ MOREDecember 19, 2022Time to read: 1 minutes
AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved VRAYLAR® (cariprazine) ; (known as Reagila in Australia) as an adjunctiv...
READ MOREDr Sanil RegeNovember 24, 2022Time to read: 33–40 minutes
Humans spend 1/3rd of their life sleeping. Sleep is critical to adaptive human functioning with its links to cognition, mood, ...
READ MOREDr Sanil RegeOctober 27, 2022Time to read: 10 minutes
Memantine is a low-affinity voltage-dependent non-competitive NMDA receptor antagonist that is approved for treating moderate-...
READ MOREDr Sanil RegeSeptember 30, 2022Time to read: 16–19 minutes
The interaction between smoking and schizophrenia is complex and multifaceted, with patients consistently showing higher rates...
READ MORESeptember 14, 2022In this video, Dr Sanil Rege reviews the ...
READ MORESeptember 5, 2022In this video, Dr Sanil Rege explores the use of network meta-analysis to make indirect comparisons between drugs that have not been compared in head-to...
READ MOREDr Sanil RegeJuly 25, 2022Time to read: 17–20 minutes
When patients with Major Depressive Disorder (MDD) don’t respond to medication, clinicians have three options: Increase dose, switch or augment....
READ MORE